Gynecomastia (Male Chest) | Basic Questions About Gynecomastia

In his practice, Dr. Vishal Purohit diagnoses gynecomastia through clinical examination and direct palpation first, using ultrasound or MRI when imaging is needed, and reserving hormone blood tests for symptoms of hormonal imbalance. Anabolic steroids can cause gynecomastia, whereas protein supplements have no role in increasing or decreasing it. Growing chest muscle can push glandular tissue outwards, making it appear more prominent. Gynecomastia is never a hard lump, which instead suggests conditions like a carcinoma or tense cyst requiring immediate imaging. True glandular proliferation differs from pseudogynecomastia, which involves excess fat and skin without glandular enlargement.

True glandular gynecomastia involves hyperplastic ductal and fibro-stromal tissue presenting on examination as a firm, elastic, mobile subareolar button or disc. In contrast, pseudogynecomastia, or lipomastia, consists of diffuse subareolar and periareolar adipose deposition without glandular ductal hyperplasia, occurring most commonly with generalized obesity where weight management serves as initial treatment. Mixed gynecomastia, the most frequent clinical presentation, combines dense parenchymal glandular hypertrophy with surrounding localized adipose tissue. Precise direct palpation differentiates fat from true glandular tissue, helping determine whether clinical observation or combined liposuction with gland excision is indicated, with imaging or hormone testing reserved for specific clinical signs.

Dr. Vishal Purohit diagnoses chest enlargement through clinical examination and direct palpation first, followed by ultrasound or MRI when imaging is required. Hormone blood tests are advised only when other symptoms of hormonal imbalance occur, with endocrinologist referral reserved for sudden development well after puberty. Gynecomastia never presents as a hard lump; a hard breast mass suggests conditions such as carcinoma or a tense cyst requiring immediate imaging and oncological referral. When surgical correction is indicated, his protocol employs dual-modality circumferential VASER or power liposuction alongside sharp hemi-periareolar gland excision, with all excised tissue sent for histopathological analysis.

In general clinical literature, gynecomastia involves excess localized fat, excess glandular tissue development, and sometimes excess breast skin, occurring in one breast or both breasts at any age. Because these tissue elements differ, enlargement caused by temporary hormonal fluctuations during puberty often resolves without medication, with surgery considered at least two years after puberty is complete. Established glandular tissue, hereditary traits, or medication-induced enlargement generally persist without surgical removal. Gynecomastia can cause significant emotional discomfort and impair self-confidence, leading men to avoid sports, physical activities, and intimacy. An in-person clinical examination and direct palpation determine whether surgical gland excision is required.

Clinical literature notes that gynecomastia involves true glandular tissue enlargement, pseudogynecomastia with fat alone, or mixed hypertrophy, graded by breast size and redundant skin. Because chest enlargement alters typical male physical contours, published studies highlight that the condition frequently induces persistent distress, marked psychological trauma, and noticeable disruption in social and emotional activities. When tissue enlargement persists beyond 12 months without responding to spontaneous regression or medical management, it is classified as recalcitrant. In such cases, surgical intervention—including glandular excision, suction-assisted lipectomy, or combined techniques—is discussed to alleviate physical discomfort, correct the anatomical deformity, and improve overall health-related quality of life.